Bahamian Ministry of Health and Public Hospitals Authority select Allscripts Sunrise
The Bahamian Ministry of Health and the Public Hospitals Authority have selected the Allscripts Sunrise platform for three hospitals and more than one hundred...
Union Insurance Chooses CSCs Insurance Software Platform
CSC a global leader in next-generation IT services and solutions, announced it has signed a multi-year agreement with Union Insurance Company, a leading provider...
BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin R...
Becton, Dickinson and Company ,a leading global medical technology company announced it has received U.S. Food and Drug Administration (FDA) clearance for its new...
Becton, Dickinson and Company Receives FDA Clearance for New Syringe Designed for Humulin ...
BD (Becton, Dickinson and Company) a leading global medical technology company, today announced it has received U.S. FDA clearance for its new syringe for...
Cincinnati Childrens/UC Health Proton Therapy Center Opens with ProBeam System from Varian
Cincinnati Children's/UC Health Proton Therapy Center officially opened today equipped with the ProBeam® System from Varian Medical Systems . Housing two treatment rooms offering...
Quick Expands Global Healthcare Logistics Service Capabilities
Provides Cold Chain Transport and Chain of Custody for Personalized Medicine, From Research and Development, to Delivery to Each Patient. Immunotherapy drugs are one of...
Pathway Health Announce Strategic Partnership with Virtual Health
Pathway Health and Virtual Health, the leading provider of population health management technology for value-based care, have announced a new strategic partnership that will...
Novartis CDK4/6 inhibitor receives FDA approval for treatment for advanced breast cancer
Novartis announced that the US FDA has granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone receptor...
Siemens Zika Test Receives FDA Emergency Use Authorization
Siemens Healthcare Diagnostics Inc. Receives Emergency Use Authorization from FDA for its VERSANT® Zika RNA 1.0 Assay (kPCR) KitThe U.S. FDA has granted Siemens...
Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients
Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart SurgeryMedtronic plc announced CE (Conformité...
